Healthcare -
Biotechnology - NASDAQ - US
$ 0.6932
-6.3 %
$ 35.9 M
Market Cap
-0.64
P/E
XLO - REVENUE
Revenue XLO - Xilio Therapeutics, Inc.
6.34 M
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR